Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graziella Filippini

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
The Cochrane Database of Systematic Reviews|March 11, 2025
Rituximab for people with multiple sclerosisGraziella Filippini, Jera Kruja, Cinzia Del Giovane
JAMA|January 28, 2016
Association of Immunotherapies With Outcomes in Relapsing-Remitting Multiple SclerosisIrene Tramacere, Cinzia Del Giovane, Graziella Filippini
The Cochrane Database of Systematic Reviews|November 8, 2021
Rituximab for people with multiple sclerosisGraziella Filippini, Jera Kruja, Cinzia Del Giovane
Journal of Clinical Epidemiology|September 19, 2021
Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instructionSilvia Minozzi, Kerry Dwan, Francesca Borrelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2009
Botulinum neurotoxins for post-stroke spasticity in adults: a systematic reviewAntonio Emanuele Elia, Graziella Filippini, Daniela Calandrella, et al.
Recenti Progressi in Medicina|September 11, 2020
[Engaging clinicians to identify and prioritize disinvestment opportunities in the treatment of neurodegenerative diseases: a qualitative study.]Anna Ciannameo, Antonio Chiarenza, Graziella Filippini, et al.
The Cochrane Database of Systematic Reviews|May 5, 2022
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosisGraziella Filippini, Silvia Minozzi, Francesca Borrelli, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|April 1, 2005
Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year periodDaniela Testa, Roberta Lovati, Massimo Ferrarini, et al.
Statistics in Medicine|July 21, 2012
Network meta-analysis models to account for variability in treatment definitions: application to dose effectsCinzia Del Giovane, Laura Vacchi, Dimitris Mavridis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 17, 2013
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosisAdriano Chiò, Edward R Hammond, Gabriele Mora, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
The Cochrane Database of Systematic Reviews|March 11, 2025
Rituximab for people with multiple sclerosisGraziella Filippini, Jera Kruja, Cinzia Del Giovane
JAMA|January 28, 2016
Association of Immunotherapies With Outcomes in Relapsing-Remitting Multiple SclerosisIrene Tramacere, Cinzia Del Giovane, Graziella Filippini
The Cochrane Database of Systematic Reviews|November 8, 2021
Rituximab for people with multiple sclerosisGraziella Filippini, Jera Kruja, Cinzia Del Giovane
Journal of Clinical Epidemiology|September 19, 2021
Reliability of the revised Cochrane risk-of-bias tool for randomised trials (RoB2) improved with the use of implementation instructionSilvia Minozzi, Kerry Dwan, Francesca Borrelli, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2009
Botulinum neurotoxins for post-stroke spasticity in adults: a systematic reviewAntonio Emanuele Elia, Graziella Filippini, Daniela Calandrella, et al.
Recenti Progressi in Medicina|September 11, 2020
[Engaging clinicians to identify and prioritize disinvestment opportunities in the treatment of neurodegenerative diseases: a qualitative study.]Anna Ciannameo, Antonio Chiarenza, Graziella Filippini, et al.
The Cochrane Database of Systematic Reviews|May 5, 2022
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosisGraziella Filippini, Silvia Minozzi, Francesca Borrelli, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|April 1, 2005
Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year periodDaniela Testa, Roberta Lovati, Massimo Ferrarini, et al.
Statistics in Medicine|July 21, 2012
Network meta-analysis models to account for variability in treatment definitions: application to dose effectsCinzia Del Giovane, Laura Vacchi, Dimitris Mavridis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 17, 2013
Development and evaluation of a clinical staging system for amyotrophic lateral sclerosisAdriano Chiò, Edward R Hammond, Gabriele Mora, et al.
Pageof 8